NASHVILLE, TN — It wasn’t only the climate that increased the risk of skin cancer for military personnel serving in Iraq and Afghanistan. Lack of sun protection also was a contributing factor, according to a new study. Results published recently… Read More
All Fail to Consistently Meet Performance Measures By Brenda L. Mooney HOUSTON — Cardiac patients and even some medical staff might assume they will receive the best ongoing care when they see a physician, not an advanced practice provider such… Read More
Subhead: Post-operative Mortality Rates Low Among ART Users By Annette M. Boyle WEST HAVEN, CT — Historically, high post-operative mortality rates among HIV-infected patients caused many physicians and patients to defer or avoid surgery all together. For today’s veterans with… Read More
CHICAGO — Chronic kidney disease (CKD) patients at the VA have insufficient knowledge about their condition, which is associated with poorer health outcomes, according to a recent study. The report, published in the Clinical Kidney Journal, suggests that effective patient-provider… Read More
MEMPHIS, TN — A new study investigated the association of body mass index with progressive loss of kidney function and all-cause mortality in U.S. veterans, finding that those who were overweight but not obese had the best clinical outcomes. The… Read More
SEATTLE — The estimated glomerular filtration rate (eGFR) tends to be lower at the VA when dialysis is initiated compared with other healthcare systems, according to a new study. The report, published recently in the Clinical Journal of the American… Read More
The VA is proving that “everything old is new again” with an unusual medical device — medicinal maggots.
For years, researchers have promoted the wonders of medical treatment customized to a patient’s specific genetic profile, but the reality in the exam room continues to be more “one size fits all.”
Raymond Schinazi, PhD, Hon DSc, still remembers how the patients lined the corridors. They were all too thin, too pale and much too weak.
VA Researchers Find Normalizing ‘T’ Levels Lowers Heart Risks By Brenda L. Mooney KANSAS CITY, MO — The question over how testosterone replacement therapy (TRT) affects cardiovascular health became even more contentious with a new U.S. veterans study finding that… Read More
By Sandra Basu WASHINGTON — If you had more money for traumatic brain injury research, where would you invest it? That is one of the questions VA Secretary Robert McDonald asked TBI researchers at a recent conference He also inquired… Read More
By Brenda L. Mooney SAN FRANCISCO – New research on cholinesterase inhibitors is reducing the already limited options VA clinicians have to treat VA patients with dementia. More than a half-million veterans have Alzheimer’s disease (AD) and dementia, with most… Read More
PLAINSBORO, NJ – Physicians treating diabetes patients have new weapons in their arsenal. The Food and Drug Administration recently approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve glucose control in adults with diabetes mellitus.… Read More
JERSEY CITY, NJ – A new option for treating schizophrenia and bipolar disorder in adults has been approved by the Food and Drug Administration. The drug Vraylar, cariprazine in capsule form, is manufactured by Forest Laboratories LLC of Jersey City,… Read More
By Brenda L. Mooney SALT LAKE CITY — A study conducted in the VA health system uncovered a disturbing truth about overuse of antibiotics: A big contributor to the problem is that some clinicians prescribe the drugs to nearly every… Read More
For 40 years, ketamine remained on the fringes of battlefield medicine. Now, the DoD has embraced ketamine both on the field and in the hospital.
A year ago, the U.S. Drug Enforcement Administration (DEA) rolled out new restrictions on hydrocodone-based painkillers, creating a painful situation for many veterans.
New Guidelines Significantly Different from AHA/ACC Document
LOS ANGELES — A new study provides the first evidence that a simple blood test could be developed to confirm the presence of beta amyloid proteins in the brain, which could help in early diagnosis of Alzheimer’s disease. No reliable… Read More
FRANKFORT, KY — The cascade of events following mild traumatic brain injury (mTBI) appears to increase the risk for developing a progressive degenerative brain disease, and researchers now are testing a treatment that might interrupt the process linking the two… Read More